G. Hotchkiss et al., Telomere loss in peripheral blood mononuclear cells may be moderately accelerated during highly active antiretroviral therapy (HAART), J ACQ IMM D, 22(5), 1999, pp. 445-452
It has been speculated that infection with HIV-1 may lead to a significant
increase in turnover, and subsequent exhaustion, of immune repopulation. Gi
ven that telomeric DNA is lost on mitotic replication, telomere lengths can
be used as an indirect gauge of this rate. We have analyzed the mean telom
ere restriction fragment lengths in peripheral blood mononuclear cells (PBM
C) from 31 patients with established, though mainly untreated, HIV infectio
n and found them to be no different than those among healthy controls. Our
results are in line with several findings in CD4(+) cell fractions but cont
radict a previous report suggesting that telomere shortening contributes to
immune failure, Interestingly, after approximately 2 years of subsequent a
ggressive antiretroviral treatment we found a telomere reduction correspond
ing to a loss of about 250 base pairs per year; this is roughly tenfold abo
ve that predicted from healthy individuals. This could partly result from n
ucleoside analogue inhibition of the natural telomere replacement enzyme, t
elomerase-a reverse transcriptase inducible in certain hematopoietic cells.
However, this may also indicate accelerated cell replacement on initiation
of optimal therapeutic regimes or result from changes in the composition o
f the PBMC pool. These results suggest careful monitoring of telomere lengt
hs during long-term HAART.